(EU) enCore Energy Common Shares - Ratings and Ratios
Uranium, Exploration, Development, Extraction
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 72.3% |
| Value at Risk 5%th | 109% |
| Relative Tail Risk | -8.15% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.20 |
| Alpha | -42.11 |
| CAGR/Max DD | 0.05 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.483 |
| Beta | 1.446 |
| Beta Downside | 1.202 |
| Drawdowns 3y | |
|---|---|
| Max DD | 76.52% |
| Mean DD | 25.82% |
| Median DD | 21.10% |
Description: EU enCore Energy Common Shares October 24, 2025
enCore Energy Corp. (NYSE MKT: EU) is a U.S.-based uranium explorer and developer focused on a portfolio of surface and ISR (in-situ recovery) projects across Texas, Wyoming, South Dakota, and New Mexico. Its primary assets include the Alta Mesa and Mesteña Grande projects in Texas, the Gas Hills and Juniper Ridge projects in Wyoming, the Dewey Burdock project in South Dakota, and the Crownpoint/Hosta Butte properties in New Mexico, together covering roughly 360,000 acres of mineral claims, leases, and fee-mineral holdings.
Key contextual drivers: (1) The spot price of uranium has hovered around $55 per pound in 2025, up from sub-$30 levels in 2022, reflecting renewed demand from U.S. nuclear reactors and supply constraints from geopolitical disruptions. (2) ISR projects, which enCore emphasizes, typically achieve production costs 30-40 % lower than conventional mining, giving the company a potential cost-advantage if it can bring any of its ISR-ready sites to commercial operation. (3) As of the most recent quarterly filing (Q2 2025), enCore reported cash and short-term investments of approximately $12 million, sufficient for near-term drilling and permitting but insufficient to fund full-scale development without additional financing.
For a deeper, data-driven assessment of EU’s valuation and risk profile, you may find the analyst tools on ValueRay useful.
Piotroski VR‑10 (Strict, 0-10) 0.0
| Net Income (-67.1m TTM) > 0 and > 6% of Revenue (6% = 2.65m TTM) |
| FCFTA -0.14 (>2.0%) and ΔFCFTA 5.11pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 271.1% (prev 171.7%; Δ 99.45pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.09 (>3.0%) and CFO -38.6m > Net Income -67.1m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 13.64 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (187.4m) change vs 12m ago 1.18% (target <= -2.0% for YES) |
| Gross Margin 3.21% (prev -16.56%; Δ 19.77pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 10.25% (prev 10.73%; Δ -0.48pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -39.33 (EBITDA TTM -72.3m / Interest Expense TTM 2.06m) >= 6 (WARN >= 3) |
Altman Z'' 0.37
| (A) 0.27 = (Total Current Assets 129.1m - Total Current Liabilities 9.47m) / Total Assets 441.9m |
| (B) -0.42 = Retained Earnings (Balance) -186.2m / Total Assets 441.9m |
| (C) -0.19 = EBIT TTM -81.1m / Avg Total Assets 430.5m |
| (D) 1.18 = Book Value of Equity 193.2m / Total Liabilities 164.1m |
| Total Rating: 0.37 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 29.36
| 1. Piotroski 0.0pt |
| 2. FCF Yield -12.24% |
| 3. FCF Margin data missing |
| 4. Debt/Equity 0.44 |
| 5. Debt/Ebitda -0.25 |
| 6. ROIC - WACC (= -36.38)% |
| 7. RoE -25.17% |
| 8. Rev. Trend 78.45% |
| 9. EPS Trend -28.51% |
What is the price of EU shares?
Over the past week, the price has changed by -6.32%, over one month by -0.74%, over three months by +19.73% and over the past year by -20.54%.
Is EU a buy, sell or hold?
- Strong Buy: 4
- Buy: 2
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the EU price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 3.7 | 39.7% |
| Analysts Target Price | 3.7 | 39.7% |
| ValueRay Target Price | 2.7 | -0.4% |
EU Fundamental Data Overview December 02, 2025
P/E Forward = 12.1065
P/S = 11.5806
P/B = 2.0565
Beta = 1.561
Revenue TTM = 44.1m USD
EBIT TTM = -81.1m USD
EBITDA TTM = -72.3m USD
Long Term Debt = 109.3m USD (from longTermDebt, last quarter)
Short Term Debt = 156.0k USD (from shortTermDebt, last quarter)
Debt = 109.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 17.9m USD (from netDebt column, last quarter)
Enterprise Value = 489.8m USD (496.2m + Debt 109.8m - CCE 116.2m)
Interest Coverage Ratio = -39.33 (Ebit TTM -81.1m / Interest Expense TTM 2.06m)
FCF Yield = -12.24% (FCF TTM -59.9m / Enterprise Value 489.8m)
FCF Margin = -135.8% (FCF TTM -59.9m / Revenue TTM 44.1m)
Net Margin = -152.1% (Net Income TTM -67.1m / Revenue TTM 44.1m)
Gross Margin = 3.21% ((Revenue TTM 44.1m - Cost of Revenue TTM 42.7m) / Revenue TTM)
Gross Margin QoQ = 43.84% (prev 30.84%)
Tobins Q-Ratio = 1.11 (Enterprise Value 489.8m / Total Assets 441.9m)
Interest Expense / Debt = 0.96% (Interest Expense 1.05m / Debt 109.8m)
Taxrate = -0.92% (negative due to tax credits) (58.0k / -6.33m)
NOPAT = -81.9m (EBIT -81.1m * (1 - -0.92%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 13.64 (Total Current Assets 129.1m / Total Current Liabilities 9.47m)
Debt / Equity = 0.44 (Debt 109.8m / totalStockholderEquity, last quarter 248.6m)
Debt / EBITDA = -0.25 (negative EBITDA) (Net Debt 17.9m / EBITDA -72.3m)
Debt / FCF = -0.30 (negative FCF - burning cash) (Net Debt 17.9m / FCF TTM -59.9m)
Total Stockholder Equity = 266.7m (last 4 quarters mean from totalStockholderEquity)
RoA = -15.19% (Net Income -67.1m / Total Assets 441.9m)
RoE = -25.17% (Net Income TTM -67.1m / Total Stockholder Equity 266.7m)
RoCE = -21.57% (EBIT -81.1m / Capital Employed (Equity 266.7m + L.T.Debt 109.3m))
RoIC = -26.92% (negative operating profit) (NOPAT -81.9m / Invested Capital 304.1m)
WACC = 9.46% (E(496.2m)/V(606.0m) * Re(11.34%) + D(109.8m)/V(606.0m) * Rd(0.96%) * (1-Tc(-0.01)))
Discount Rate = 11.34% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 8.05%
Fair Price DCF = unknown (Cash Flow -59.9m)
EPS Correlation: -28.51 | EPS CAGR: 11.63% | SUE: 0.0 | # QB: 0
Revenue Correlation: 78.45 | Revenue CAGR: 151.5% | SUE: 0.89 | # QB: 1
EPS next Year (2026-12-31): EPS=-0.11 | Chg30d=N/A | Revisions Net=-2 | Growth EPS=+72.4% | Growth Revenue=+108.2%
Additional Sources for EU Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle